The French EsoGastricTumours Data Base
ConditionEsophageal Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorUniversity Hospital, Lille
About this trial
This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.
Eligibility criteria
Qualifiers
esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
Naive treatment for this cancer,
Naive treatment for this cancer , failing that received neoadjuvant treatment ,
Male or female ≥ 18 years.
Disqualifiers
Private person of liberty or under supervision (including guardianship ) .
People who do not speak French.
Major Nobody unable to consent .
Patient FREGAT already included in the base.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
University Hospital, Lille
Lead sponsor
French Eso-Gastric Tumors Working Group
Collaborator
National Cancer Institute, France
Collaborator
Source ClinicalTrials.gov